Showing 981 - 1,000 results of 6,525 for search '"cardiovascular"', query time: 0.10s Refine Results
  1. 981
  2. 982

    Elevated Fasting C-Peptide Levels Correlate with Increased 10-Year Risk of Atherosclerotic Cardiovascular Disease in Newly Diagnosed Type 2 Diabetes Patients by Zha XY, Wei CS, Dong JJ, Wu JZ, Xie LX, Xu ZH, Zheng HQ, Huang DB, Lai PB

    Published 2025-01-01
    “…Xiao-Yun Zha, Chang-Shun Wei, Jia-Jia Dong, Jin-Zhi Wu, Liang-Xiao Xie, Ze-Hong Xu, Hua-Qiang Zheng, Duo-Bin Huang, Peng-Bin Lai The First Department of Endocrinology and Metabolism, Zhangzhou Affiliated Hospital of Fujian Medical University, Zhangzhou, Fujian, 363000, People’s Republic of ChinaCorrespondence: Peng-Bin Lai, The First Department of Endocrinology and Metabolism, Zhangzhou Affiliated Hospital of Fujian Medical University, Zhangzhou, Fujian, 363000, People’s Republic of China, Tel +8613709398727, Email 13709398727@163.comPurpose: This study aims to analyze the impact of serum C-peptide levels in patients with newly diagnosed type 2 diabetes (T2DM) on the 10-year risk of atherosclerotic cardiovascular disease (ASCVD).Patients and Methods: A total of 1923 patients with newly diagnosed T2DM were selected and categorized into four groups based on the interquartile range of fasting C-peptide (FCP) levels: Q1 group (FCP≤ 0.568 ng/mL), Q2 group (0.568 < FCP≤ 0.751 ng/mL), Q3 group (0.751 < FCP≤ 0.980 ng/mL), and Q4 group (FCP > 0.980 ng/mL). …”
    Get full text
    Article
  3. 983

    The Effect of Vitamin D Supplementation on Glycemic Control and Cardiovascular Risk Factors in Type 2 Diabetes: An Updated Systematic Review and Meta-Analysis of Clinical Trials by Maryam Afraie, Pourya Bahrami, Parisa Kohnepoushi, Sorour Khateri, Lobat Majidi, Lotfollah Saed, Kamran Zamani, Hedyeh Mohammadi Baharm, Yousef Moradi, Farhad Moradpour

    Published 2024-01-01
    “…Based on the combined evidence, the findings of this meta-analysis suggest that vitamin D supplementation can significantly improve glycemic control and reduce the risk of complications associated with T2DM, especially cardiovascular diseases (CVDs).…”
    Get full text
    Article
  4. 984
  5. 985

    Risk of stroke associated with proton pump inhibitor use among individuals with and without pre-existing cardiovascular diseases: a systematic review and meta-analysis by Muhammed Shabil, Bijaya K. Padhi, Mahalaqua Nazli Khatib, Soumya V. Menon, Mandeep Kaur, Mukesh Kumari, Puneet Sudan, K. Satyam Naidu, Quazi Syed Zahiruddin, Sarvesh Rustagi, Divya Sharma, Mithhil Arora, Rakesh Kumar Sharma, Edward Mawejje, Prakasini Satapathy, Sanjit Sah

    Published 2025-01-01
    “…Abstract Background Proton pump inhibitors (PPIs) are commonly used for managing gastroesophageal disorders but concerns about their potential association with increased stroke risk have emerged, especially among patients with pre-existing cardiovascular conditions such as acute coronary syndrome (ACS). …”
    Get full text
    Article
  6. 986
  7. 987
  8. 988

    Does Good Aerobic Capacity Attenuate the Effects of Aging on Cardiovascular Risk Factors? Results from a Cross-Sectional Study in a Latino Population by Giovanna Valentino, Mónica Acevedo, Lorena Orellana, María José Bustamante, Verónica Kramer, Marcela Adasme, Fernando Baraona, Gastón Chamorro, Jorge Jalil, Carlos Navarrete

    Published 2017-01-01
    “…High aerobic capacity is associated with low cardiovascular (CV) risk. The aim of this study was to determine the CV RF burden in subjects with aerobic capacity ≥10 METs and compare it with those having <10 METs. …”
    Get full text
    Article
  9. 989
  10. 990
  11. 991
  12. 992
  13. 993

    Associations of daily step count with all-cause mortality and cardiovascular mortality in hypertensive US adults: a cohort study from NHANES 2005–2006 by Tuo Guo, Yang Zhou, Guifang Yang, Aifang Zhong, Xiaogao Pan, Yuting Pu, Michael Simons, Lijuan Sheng, Xiangping Chai

    Published 2025-01-01
    “…This study investigates the association between daily step count and both all-cause and cardiovascular mortality in hypertensive American adults. …”
    Get full text
    Article
  14. 994
  15. 995

    Associations of Plasma Phospholipid Omega-6 and Omega-3 Polyunsaturated Fatty Acid Levels and MRI Measures of Cardiovascular Structure and Function: The Multiethnic Study of Atherosclerosis by Jennifer S. Anderson, Jennifer A. Nettleton, W. Gregory Hundley, Michael Y. Tsai, Lyn M. Steffen, Rozenn N. Lemaitre, David Siscovick, João Lima, Martin R. Prince, David Herrington

    Published 2011-01-01
    “…The association between plasma omega-6 fatty acids and cardiovascular disease (CVD) is unclear, and discrepancy remains concerning the cardiovascular benefit of the omega-3 fatty acid alpha-linolenic acid. …”
    Get full text
    Article
  16. 996

    Effects of inulin-type fructans supplementation on cardiovascular disease risk factors: a protocol for a systematic review and meta-analysis of randomised controlled trials by Russell J de Souza, Lawrence Mbuagbaw, John L Sievenpiper, Dena Zeraatkar, Laura Banfield, Vanessa Ha, David J A Jenkins, Jhalok Ronjan Talukdar, Matthew Adam Cooper, Lyuba Lyutvyn, Rahim Ali, Rachel Bierbrier, Sabrina Janes, Pauline B Darling

    Published 2022-07-01
    “…The RCTs need to administer ITF in adults for at least 2 weeks and assess effects on at least one cardiovascular risk factor. We will exclude RCTs that (1) assessed the postprandial effects of ITF; (2) included pregnant or lactating participants; (3) enrolled participants undergoing treatment that might affect the response to ITF. …”
    Get full text
    Article
  17. 997
  18. 998

    Impact of a nurse-led teleconsultation strategy for cardiovascular disease management during COVID-19 pandemic in India: a pyramid model feasibility study by Dorairaj Prabhakaran, Kavita Singh, Ambuj Roy, Bishav Mohan, Rohit Tandon, Abhishek Goyal, Bhupinder Singh, Shibba Takkar Chhabra, Naved Aslam, Gurpreet Singh Wander, Nitish Naik, Gurbhej SIngh, Shivaansh Aggarwal, Aftabh Saini

    Published 2022-07-01
    “…Objective The COVID-19 pandemic necessitated the use of telemedicine to maintain continuity of care for patients with cardiovascular diseases (CVDs). This study aimed to demonstrate the feasibility of implementing a nurse-led teleconsultation strategy for CVD management during the COVID-19 pandemic in India and evaluated the impact of nurse-led teleconsultations on patient treatment satisfaction.Design, setting and participants We developed a two-stage teleconsultation strategy and tested the feasibility of implementing a nurse-led teleconsultation strategy to manage CVD in a northern state (Punjab) in India. …”
    Get full text
    Article
  19. 999

    Association of serum uric acid, morning home blood pressure and cardiovascular risk factors in a population with previous prehypertension: a cross-sectional study by Lucky Aziza Bawazier, Mochammad Sja'bani, Fredie Irijanto, Zulaela Zulaela, Agus Widiatmoko, Abdul Kholiq, Yasuhiko Tomino

    Published 2020-09-01
    “…Objective To observe the changes in blood pressure (BP) over 10 years and to investigate current BP association to serum uric acid (SUA) levels and cardiovascular risk factors in the epidemiological data of a target group of patients with prehypertension in 2007.Design Cross-sectional study.Setting Mlati Subdistrict, Sleman District, Yogyakarta Province, Indonesia.Participants A total of 733 patients from ‘Mlati Study Database’ in 2007 were selected by simple random sampling using statistical software. …”
    Get full text
    Article
  20. 1000